Which has grown faster, ANGO or SOPH?

Over the past five years, SOPH grew revenue faster — ANGO at a 1.93% CAGR versus SOPH at 20.33%.

How have ANGO and SOPH total returns compared?

Over the past 5 years, ANGO delivered -10.80% and SOPH delivered -13.62% annualized total return. Past performance doesn't predict future results.

AngioDynamics, Inc. (ANGO) vs SOPHiA GENETICS S.A. (SOPH)

A side-by-side comparison of AngioDynamics, Inc. and SOPHiA GENETICS S.A. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ANGO

AngioDynamics, Inc.

$596M

$14.42HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

SOPH

SOPHiA GENETICS S.A.

$619M

$7.38HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — ANGO vs SOPH

growth of $100 · dividends reinvested · last 5y

ANGO -37.2% (-8.9%/yr)SOPH -51.1% (-13.3%/yr)ANGO compounded faster over this window

ANGO SOPH

ANGO vs SOPH: by the numbers

•SOPH is the larger company ($619M vs $596M market cap).
•Both run net losses; ANGO's is the smaller (-11.48% vs -93.86% net margin).
•SOPH grew revenue faster over the past five years (20.33% vs 1.93% CAGR).

Metrics side by side

Valuation

Metric	ANGO	SOPH
P/S ratio	1.86	7.19
P/B ratio	3.49	7.45
FCF yield	0.09%	N/A

Profitability

Metric	ANGO	SOPH
Gross margin	54.62%	66.63%
Operating margin	-12.47%	-85.01%
Net margin	-11.48%	-93.86%
ROE	-21.51%	-97.31%
ROIC	-20.75%	-49.73%

Growth (annualized)

Metric	ANGO	SOPH
Revenue CAGR (5Y)	1.93%	20.33%
FCF CAGR (5Y)	-51.49%	N/A
Total return CAGR (5Y)	-10.80%	-13.62%

Frequently asked

Which has grown faster, ANGO or SOPH?: Over the past five years, SOPH grew revenue faster — ANGO at a 1.93% CAGR versus SOPH at 20.33%.
How have ANGO and SOPH total returns compared?: Over the past 5 years, ANGO delivered -10.80% and SOPH delivered -13.62% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ANGO analysis Full SOPH analysis Interactive comparison tool

Dig into the metrics

AngioDynamics ROE SOPHiA GENETICS ROE AngioDynamics operating margin SOPHiA GENETICS operating margin AngioDynamics revenue growth SOPHiA GENETICS revenue growth AngioDynamics free cash flow SOPHiA GENETICS free cash flow

AngioDynamics & SOPHiA GENETICS appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.